A detailed history of Silver Oak Securities, Inc transactions in Pfizer Inc stock. As of the latest transaction made, Silver Oak Securities, Inc holds 13,967 shares of PFE stock, worth $352,387. This represents 0.04% of its overall portfolio holdings.

Number of Shares
13,967
Previous 10,481 33.26%
Holding current value
$352,387
Previous $293,000 37.88%
% of portfolio
0.04%
Previous 0.05%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$27.7 - $31.39 $96,562 - $109,425
3,486 Added 33.26%
13,967 $404,000
Q2 2024

Jul 12, 2024

SELL
$25.26 - $29.6 $12,528 - $14,681
-496 Reduced 4.52%
10,481 $293,000
Q1 2024

May 10, 2024

SELL
$25.89 - $29.73 $61,902 - $71,084
-2,391 Reduced 17.89%
10,977 $304,000
Q4 2023

Feb 05, 2024

BUY
$26.13 - $33.94 $118,159 - $153,476
4,522 Added 51.12%
13,368 $384,000
Q3 2023

Nov 20, 2023

SELL
$32.09 - $37.51 $188,432 - $220,258
-5,872 Reduced 39.9%
8,846 $293,000
Q2 2023

Aug 02, 2023

BUY
$36.12 - $41.79 $13,039 - $15,086
361 Added 2.51%
14,718 $539,000
Q1 2023

May 05, 2023

BUY
$39.39 - $51.28 $13,983 - $18,204
355 Added 2.54%
14,357 $586,000
Q4 2022

Feb 02, 2023

BUY
$41.75 - $54.5 $2,588 - $3,379
62 Added 0.44%
14,002 $717,000
Q3 2022

Oct 23, 2023

SELL
$43.76 - $53.42 $256,958 - $313,682
-5,872 Reduced 39.9%
8,846 $387,000
Q3 2022

Oct 20, 2022

BUY
$43.76 - $53.42 $12,296 - $15,011
281 Added 2.06%
13,940 $610,000
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $17,448 - $20,688
-375 Reduced 2.67%
13,659 $701,000
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $642,055 - $795,587
14,034 New
14,034 $771,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $142B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Silver Oak Securities, Inc Portfolio

Follow Silver Oak Securities, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silver Oak Securities, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Silver Oak Securities, Inc with notifications on news.